STEVENSON, Md. -- (Business Wire)
The securities litigation law firm of Brower Piven, A Professional
Corporation, has commenced an investigation into possible breaches of
fiduciary duty and other violations of state law by the Board of
Directors of Medivation, Inc. (NASDAQ: MDVN) (“Medivation” or the
“Company”) relating to the proposed buyout of Medivation by Pfizer Inc.
Under the terms of the agreement, Medivation shareholders are
anticipated to receive $81.50 in cash for each share of Medivation
common stock held. The firm’s investigation seeks to determine, among
other things, whether the Company’s Board of Directors failed to satisfy
their duties to shareholders, including whether the Board adequately
pursued alternatives to the acquisition and whether the Board obtained
the best price possible for the Company’s shares of common stock.
If you currently own common stock of Medivation and believe that the
proposed buyout price is too low, or you would like to learn more about
the investigation being conducted by Brower Piven, please visit our
website at http://www.browerpiven.com/currentinvestigations.html.
You may also request more information by contacting Brower Piven either
by email at hoffman@browerpiven.com
or by telephone at (410) 415-6616.
Attorneys at Brower Piven have extensive experience in litigating
securities and other class action cases and have been advocating for the
rights of shareholders since the 1980s.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160825006139/en/
Contacts:
Brower Piven, A Professional Corporation
Charles J. Piven,
410-415-6616
1925 Old Valley Road
Stevenson, Maryland 21153
hoffman@browerpiven.com
Source: Brower Piven, A Professional Corporation
© 2024 Canjex Publishing Ltd. All rights reserved.